These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15857827)

  • 1. A novel peroxisome proliferator-activated receptor gamma isoform with dominant negative activity generated by alternative splicing.
    Sabatino L; Casamassimi A; Peluso G; Barone MV; Capaccio D; Migliore C; Bonelli P; Pedicini A; Febbraro A; Ciccodicola A; Colantuoni V
    J Biol Chem; 2005 Jul; 280(28):26517-25. PubMed ID: 15857827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1.
    Cheng S; Afif H; Martel-Pelletier J; Pelletier JP; Li X; Farrajota K; Lavigne M; Fahmi H
    J Biol Chem; 2004 May; 279(21):22057-65. PubMed ID: 15023995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms.
    Pandhare J; Cooper SK; Phang JM
    J Biol Chem; 2006 Jan; 281(4):2044-52. PubMed ID: 16303758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo.
    Itami A; Watanabe G; Shimada Y; Hashimoto Y; Kawamura J; Kato M; Hosotani R; Imamura M
    Int J Cancer; 2001 Nov; 94(3):370-6. PubMed ID: 11745416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator.
    Tien ES; Davis JW; Vanden Heuvel JP
    J Biol Chem; 2004 Jun; 279(23):24053-63. PubMed ID: 15051727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of peroxisome proliferator-activated receptor gamma1 splice variants in human colorectal cell lines.
    Fiatte C; Huin C; Bertin I; Lesuffleur T; Pluvinet A; Touche N; Plénat F; Dauça M; Domenjoud L; Schohn H
    Int J Oncol; 2006 Dec; 29(6):1601-10. PubMed ID: 17089002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes.
    Liu J; Farmer SR
    J Biol Chem; 2004 Oct; 279(43):45020-7. PubMed ID: 15308623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells.
    Rashid-Kolvear F; Taboski MA; Nguyen J; Wang DY; Harrington LA; Done SJ
    BMC Cancer; 2010 Jul; 10():390. PubMed ID: 20650001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
    Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
    Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
    Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
    Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells.
    Kitamura S; Miyazaki Y; Shinomura Y; Kondo S; Kanayama S; Matsuzawa Y
    Jpn J Cancer Res; 1999 Jan; 90(1):75-80. PubMed ID: 10076568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARγΔ5, a Naturally Occurring Dominant-Negative Splice Isoform, Impairs PPARγ Function and Adipocyte Differentiation.
    Aprile M; Cataldi S; Ambrosio MR; D'Esposito V; Lim K; Dietrich A; Blüher M; Savage DB; Formisano P; Ciccodicola A; Costa V
    Cell Rep; 2018 Nov; 25(6):1577-1592.e6. PubMed ID: 30404011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation.
    Bouaboula M; Hilairet S; Marchand J; Fajas L; Le Fur G; Casellas P
    Eur J Pharmacol; 2005 Jul; 517(3):174-81. PubMed ID: 15987634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.
    Baek SJ; Kim JS; Nixon JB; DiAugustine RP; Eling TE
    J Biol Chem; 2004 Feb; 279(8):6883-92. PubMed ID: 14662774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARgamma agonists inhibit cell growth and suppress the expression of cyclin D1 and EGF-like growth factors in ras-transformed rat intestinal epithelial cells.
    Kitamura S; Miyazaki Y; Hiraoka S; Nagasawa Y; Toyota M; Takakura R; Kiyohara T; Shinomura Y; Matsuzawa Y
    Int J Cancer; 2001 Nov; 94(3):335-42. PubMed ID: 11745411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasis.
    D'Argenio G; Petillo O; Margarucci S; Torpedine A; Calarco A; Koverech A; Boccia A; Paolella G; Peluso G
    J Biol Chem; 2010 Aug; 285(35):27078-27087. PubMed ID: 20558736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excision of the first intron from the gonadotropin-releasing hormone (GnRH) transcript serves as a key regulatory step for GnRH biosynthesis.
    Son GH; Jung H; Seong JY; Choe Y; Geum D; Kim K
    J Biol Chem; 2003 May; 278(20):18037-44. PubMed ID: 12639969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative splicing of human peroxisome proliferator-activated receptor delta (PPAR delta): effects on translation efficiency and trans-activation ability.
    Lundell K; Thulin P; Hamsten A; Ehrenborg E
    BMC Mol Biol; 2007 Aug; 8():70. PubMed ID: 17705821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of divergent effects of activated peroxisome proliferator-activated receptor-γ on mitochondrial citrate carrier expression in 3T3-L1 fibroblasts and mature adipocytes.
    Bonofiglio D; Santoro A; Martello E; Vizza D; Rovito D; Cappello AR; Barone I; Giordano C; Panza S; Catalano S; Iacobazzi V; Dolce V; Andò S
    Biochim Biophys Acta; 2013 Jun; 1831(6):1027-36. PubMed ID: 23370576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation.
    Yang CC; Wang YC; Wei S; Lin LF; Chen CS; Lee CC; Lin CC; Chen CS
    Cancer Res; 2007 Apr; 67(7):3229-38. PubMed ID: 17409431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.